Preoperative subpterygeal injection of bevacizumab Vs mitomycin C for pterygium surgery
Phase 2
- Conditions
- Pterygium.Excl.psudopterygium(H11.8)
- Registration Number
- IRCT2016042227525N1
- Lead Sponsor
- Voice Chancellor for Research - Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Primary pterygium
Exclusion criteria;: Pregnancy ; history of pterygium surgery; glaucoma; trachoma ; autoimmune disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pterygium thickness. Timepoint: Preoperative subpterygeal njection and 1 month after injectin of mitomycin C and bevacizumab. Method of measurement: Anterior segment OCT.;Endothelial cell count. Timepoint: Preoperative subpterygeal injection and 1 ,3, 6 month after pterygium surgery. Method of measurement: Specular microscopy.
- Secondary Outcome Measures
Name Time Method Recurrence rate of pterygium. Timepoint: 6 months after pterygium surgery. Method of measurement: Eye examination with Slit-lamp biomicroscope.